Noel G. McElvaney - Concepedia

Author

Noel G. McElvaney

Royal College of Surgeons in Ireland ORCID

Also Known As

Boucher, Richard, Clapp, Phillip W, G McElvaney, G. MCElvaney, G. McElvaney, G. Mcelvaney, G. N. Mcelvaney, G.G. Mcelvaney, GERARD N. MCELVANEY, Gerald McElvaney

639

Publications

25.2K

Citations

H-Index

187

Concepts

All Affiliations

Royal College of Surgeons in Ireland Beaumont Hospital Trinity College Dublin National Heart Lung and Blood Institute National Institutes of Health

About

Noel G. McElvaney is an author at Royal College of Surgeons in Ireland specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	82	8K
2	Health Sciences	4	4	356
3	Engineering	3	3	73
4	Education	2	2	182
5	Natural Sciences	2	2	210

Noel G. McElvaney

200

Publications

19.7K

Citations

H-Index

Page 1

	Year	Citations
A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney, New England Journal of Medicine	2011	2.1K
Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis Ronald G. Crystal, Noel G. McElvaney, Melissa A. Rosenfeld, Nature Genetics Human Cftr CdnaRespiratory TractPathologyVirologyRespiratory Infection	1994	827
Characterization of the Inflammatory Response to Severe COVID-19 Illness Oliver J. McElvaney, Natalie McEvoy, Oisín F. McElvaney, American Journal of Respiratory and Critical Care Medicine	2020	665
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, The Lancet Lung DensityPulmonary PharmacologyPlacebo-controlled TrialPulmonary MedicineIntravenous Augmentation Treatment	2015	494
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. Hidenori Nakamura, Kazuya Yoshimura, Noel G. McElvaney, Journal of Clinical Investigation InflammationCytokineInflammatory Lung DiseaseLung InflammationImmunology	1992	491
Systemic deficiency of glutathione in cystic fibrosis James H. Roum, Roland Buhl, Noel G. McElvaney, Journal of Applied Physiology AsthmaInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunology	1993	393
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. P. Birrer, Noel G. McElvaney, A Rüdeberg, American Journal of Respiratory and Critical Care Medicine AsthmaInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunology	1994	381
Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α <sub>1</sub> -Antitrypsin: Interim Results Terence R. Flotte, Bruce C. Trapnell, Margaret Humphries, Human Gene Therapy	2011	322
Aerosol α1 -antitrypsin treatment for cystic fibrosis Noel G. McElvaney, Richard C. Hubbard, P. Birrer, The Lancet MedicinePulmonary PharmacologyPulmonary FibrosisPulmonary MedicinePharmacology	1991	320
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. Noel G. McElvaney, Hidenori Nakamura, P. Birrer, Journal of Clinical Investigation InflammationAsthmaCytokineInflammatory Lung DiseaseAutoimmune Disease	1992	297

Page 1